In the beginning: Genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly

Journal of General Virology

Volumn 81, Issue 8, 2000, Pages 1889-1899

  Jewell, N A ^a   Mansky, L M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDRITHIOL 2; ANTIVIRUS AGENT; GAG PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; ZINC FINGER PROTEIN;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; BOVINE LEUKEMIA VIRUS; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DRUG TARGETING; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; MOUSE MAMMARY TUMOR ONCOVIRUS; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN RNA BINDING; REVIEW; SEQUENCE ANALYSIS; SPUMA VIRUS; STRUCTURE ACTIVITY RELATION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS GENOME; VIRUS INACTIVATION; VIRUS REPLICATION;

BOVINAE; BOVINE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T-LYMPHOTROPIC VIRUS 1; MAMMARY TUMOR ONCOVIRUS; MIRIDAE; MOUSE MAMMARY TUMOR VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; ONCOVIRINAE; RNA VIRUSES; SPUMAVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0033885963     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-8-1889     Document Type: Review

References (56)

1. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: A candidate SIV vaccine
2. The galvanization of biology: A growing appreciation for the roles of zinc
3. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric gag polyproteins during RNA packaging in vivo
4. RNA packaging
5. Human immunodeficiency virus type 1 gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein
6. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA
7. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element
8. A novel nuclear export activity in HIV-1 matrix protein required for viral replication
9. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle
10. Identification of sites that act together to direct dimerization of human foamy virus RNA in vitro
11. Sequences in pol are required for transfer of human foamy virus-based vectors
12. HIV-1 Gag proteins: Diverse functions in the virus life cycle
13. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent
14. Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line
15. Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors
16. An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA
17. Bovine leukemia virus matrix-associated protein MA(p15): Further processing and formation of a specific complex with the dimer of the 5' terminal genomic RNA fragment
18. Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding close relation to the packaging sites of avian, murine, and human retroviruses
19. A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging
20. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: A possible role for the p2 domain of Gag in RNA encapsidation
21. Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation
22. cis-Acting sequences involved in human immunodeficiency virus type 1 RNA packaging
23. Zinc finger peptides for the regulation of gene expression
24. Foamy viruses are unconventional retroviruses
25. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin
26. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA
27. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures
28. Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo
29. Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis-elements required for encapsidation
30. Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2
31. Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS
32. The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5' end of the gag gene
33. The bovine leukemia virus encapsidation signal is composed of RNA secondary structures
34. Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly
35. cis-Active structural motifs involved in specific encapsidation of moloney murine leukemia virus RNA
36. Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: Anti-retroviral effect demonstrated in vivo
37. RNA dimerization defect in a Rous sarcoma virus matrix mutant
38. Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus
39. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity
40. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging
41. Efficient HIV-1 replication can occur in the absence of the viral matrix protein
42. Retroviral RNA packaging: A review
43. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: Significance for viral replication
44. Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein
45. Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro
46. Distinct functions and requirements for the cys-his boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replication
47. Synthesis, assembly, and processing of viral proteins
48. Azodicarbonamide inhibits T-cell responses in vitro and in vivo
49. Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein
50. cis-Acting sequences required for simian foamy virus type 1 vectors
51. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains
52. Evidence that the human foamy virus genome is DNA
53. The major HIV-1 packaging signal is an extended bulged stem loop whose structure is altered on interaction with the Gag polyprotein
54. Analysis of the assembly function of the human immunodeficiency virus type 1 Gag protein nucleocapsid domain